NEURONET is a Coordination and Support Action (CSA) aiming to support and better integrate projects in the Innovative Medicines Initiative (IMI) Neurodegenerative Disorders (ND) portfolio. WP1 Projects & Impact Analysis is a descriptive and methodological work package (WP) that collects information (e.g., scope, deliverables, funding etc.) about IMI ND projects to enable an integrated view of the IMI ND project portfolio in terms of relative specialisation, timelines, expertise, and outputs. As part of WP1 activities, NEURONET conducted an analysis of IMI ND projects at the programme level in order to obtain the first integrated view of the portfolio (Deliverable 1.2). This deliverable reports an update to the first approach, representing five new projects that have been added to the IMI ND portfolio. This deliverable also provides a refined understanding of the portfolio’s project outputs and potential synergies.